KEY FEATURES
| Full Name | Mothers Against Decapentaplegic Homolog 4 |
|---|---|
| Synonym | DPC4; JIP; MADH4; Deletion target in pancreatic carcinoma 4 |
| Assay Type | Sandwich |
| Reactivity | Human |
| Range | 0.31-20ng/mL |
| Sensitivity | 0.13ng/mL |
| Sample Type | Serum,plasma and other biological fluids |
| Sample Volume | 100μL |
| Detection Wavelength | OD450 |
| Transportation Temperature | 2-8°C |
| Specificity | The kit detected Human Smad4 in the samples and no significant cross-species reactions were found |
| Microplate | 96-wells plate breakable into 12 x 8 wells strip |
TEST PRINCIPLE
| This ELISA kit uses the Sandwich-ELISA principle. The micro ELISA plate provided in this kit has been pre-coated with an antibody specific to Human Smad4. Standards or samples are added to the micro ELISA plate wells and combined with the specific antibody. Then a biotinylated detection antibody specific for Human Smad4 and Avidin-Horseradish Peroxidase (HRP) conjugate are added successively to each micro plate well and incubated. Free components are washed away. The substrate solution is added to each well. Only those wells that contain Human Smad4, biotinylated detection antibody and Avidin-HRP conjugate will appear blue in color. The enzyme-substrate reaction is terminated by the addition of stop solution and the color turns yellow. The optical density (OD) is measured spectrophotometrically at a wavelength of 450 nm ± 2 nm. The OD value is proportional to the concentration of Human Smad4. You can calculate the concentration of Human Smad4 in the samples by comparing the OD of the samples to the standard curve. |
ELISA KIT COMPONENTS
Upon receipt, unpack promptly and store as recommended in the instructions.
| Components | Specifications | Storage and Notes |
|---|---|---|
| Micro Plate | 96T: 8 wells×12 strips 48T: 8 wells×6 strips | Unopened: -20°C, 12 months Unused: Put it back in the aluminum foil bag and seal it, store it at -20°C. |
| Reference Standard | 96T: 2 vials 48T: 1 vial | Unopened: -20°C, 12 months Please use freshly dissolved standards for each experiment. Discard any unused standards after dissolution. |
| Biotinylated Detection Ab Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C, 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| HRP Conjugate Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C(Protect from light), 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| Biotinylated Detection Ab Diluent | 14mL×1 | 2-8℃, 12 months |
| HRP Conjugate Diluent | 14mL×1 | 2-8℃, 12 months |
| Reference Standard & Sample Diluent | 20mL×1 | 2-8℃, 12 months |
| Washing Buffer Concentrate (25×) | 30mL×1 | 2-8℃, 12 months |
| Substrate Reagent(TMB) | 10mL×1 | 2-8°C(Protect from light),12 months |
| Stop Solution | 7mL×1 | 2-8°C/Room temperature |
ASSAY PROCEDURES

TYPICAL DATA

Human Smad4 ELISA Standard Curve
Typical data are for reference only and curves should be replotted for each experiment. The Logistics function is recommended for fitting.
PRECISION
Intra-Assay Precision (Precision within an assay): Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision.
Inter-Assay Precision (Precision between assays): Three samples of known concentration were tested in twenty separate assays to assess inter-assay precision. Assays were performed by at least three technicians using two lots of components.
| Intra-assay Precision | Inter-assay Precision | |||||
|---|---|---|---|---|---|---|
| Sample | 1 | 2 | 3 | 1 | 2 | 3 |
| n | 20 | 20 | 20 | 20 | 20 | 20 |
| Mean (ng/mL) | 0.98 | 2.08 | 7.61 | 0.93 | 2.17 | 7.28 |
| Standard deviation | 0.06 | 0.12 | 0.39 | 0.05 | 0.09 | 0.28 |
| CV(%) | 6.22 | 5.76 | 5.07 | 5.28 | 4.16 | 3.82 |
RECOVERY
The recovery of Human Smad4 spiked to three different levels in samples throughout the range of the assay in various matrices was evaluated.
| Sample Type | Range (%) | Average Recovery (%) |
|---|---|---|
| Serum(n=8) | 95-108 | 100 |
| EDTA plasma (n=8) | 84-96 | 91 |
| Cell culture media (n=8) | 89-102 | 95 |
LINEARITY
To assess the linearity of the assay, samples containing and/or spiked with high concentrations of Human Smad4 in various matrices were diluted with the Reference Standard & Sample Diluent to produce samples with values within the dynamic range of the assay.

Products associated with Smad4 ELISA Kits
| SMAD2 ELISA Kit | publications with Smad4 and SMAD2 |
| SMAD3 ELISA Kit | publications with Smad4 and SMAD3 |
| SMAD1 ELISA Kit | publications with Smad4 and SMAD1 |
| SKI ELISA Kit | publications with Smad4 and SKI |
| SP1 ELISA Kit | publications with Smad4 and SP1 |
| FOXH1 ELISA Kit | publications with Smad4 and FOXH1 |
| TRIM33 ELISA Kit | publications with Smad4 and TRIM33 |
| EP300 ELISA Kit | publications with Smad4 and EP300 |
| PIAS4 ELISA Kit | publications with Smad4 and PIAS4 |
| UBC ELISA Kit | publications with Smad4 and UBC |
Pathways associated with Smad4 ELISA Kit
| ALK1 Signaling Events Pathway | ALK1 Signaling Events Pathway |
| ALK2 Signaling Events Pathway | ALK2 Signaling Events Pathway |
| Activin Signaling Pathway | Activin Signaling Pathway |
| Adherens Junction Pathway | Adherens Junction Pathway |
| Androgen Receptor Signaling Pathway | Androgen Receptor Signaling Pathway |
| BMP Signalling Pathway | BMP Signalling Pathway |
| BMP Receptor Signaling Pathway | BMP Receptor Signaling Pathway |
| BMP Signaling Pathway | BMP Signaling Pathway |
Diseases associated with Smad4 ELISA Kit
| Colorectal Neoplasms | publications with Smad4 and Colorectal Neoplasms |
| Fibrosis | publications with Smad4 and Fibrosis |
| Liver Diseases | publications with Smad4 and Liver Diseases |
| Liver Neoplasms | publications with Smad4 and Liver Neoplasms |
| Cell Transformation, Neoplastic | publications with Smad4 and Cell Transformation, Neoplastic |
| Neoplasms, Experimental | publications with Smad4 and Neoplasms, Experimental |
| Inflammation | publications with Smad4 and Inflammation |
| Stomach Neoplasms | publications with Smad4 and Stomach Neoplasms |
| Carcinoma, Hepatocellular | publications with Smad4 and Carcinoma, Hepatocellular |
| Juvenile polyposis syndrome | publications with Smad4 and Juvenile polyposis syndrome |
Organs/Tissues associated with Smad4 ELISA Kit
| Bone | publications with Smad4 and Bone |
| Liver | publications with Smad4 and Liver |
| Blood | publications with Smad4 and Blood |
| Muscle | publications with Smad4 and Muscle |
| Pancreas | publications with Smad4 and Pancreas |
| Lung | publications with Smad4 and Lung |
| Vascular | publications with Smad4 and Vascular |
| Embryonic Tissue | publications with Smad4 and Embryonic Tissue |
| Kidney | publications with Smad4 and Kidney |
| Skin | publications with Smad4 and Skin |